Israel Research Finds Merck's Singulair Could Replace Tonsillectomies
This article was originally published in PharmAsia News
Executive Summary
Israeli researchers said Merck's Singulair (montelukast) anti-inflammatory drug for treating asthma could replace tonsillectomies to resolve sleep-related respiratory disorders in some children.